Literature DB >> 15102345

Leptomeningeal metastases.

Alexis Demopoulos1.   

Abstract

Leptomeningeal metastasis, also known as neoplastic meningitis, carcinomatous meningitis, and meningeal carcinomatosis, occurs when cancer cells gain access to cerebrospinal fluid pathways, travel to multiple sites within the central nervous system, settle, and grow. This disease has become an increasingly important late complication in oncology as patients survive longer, develop more brain metastases, and newer chemotherapies fail to penetrate the blood-brain barrier. The hallmark of clinical presentation is a cancer patient who complains of focal neurologic dysfunction and is found to have multifocal signs on neurologic examination. The clinical course is relentlessly progressive; treatment is limited and cures are the subject of case reports. This article reviews the clinical course of leptomeningeal metastasis and addresses recent developments in its pathophysiology, diagnosis, and treatment.

Entities:  

Mesh:

Year:  2004        PMID: 15102345     DOI: 10.1007/s11910-004-0039-z

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  54 in total

Review 1.  Diffuse leptomeningeal oligodendrogliomatosis: radiologic/pathologic correlation.

Authors:  D M Armao; J Stone; M Castillo; K M Mitchell; T W Bouldin; K Suzuki
Journal:  AJNR Am J Neuroradiol       Date:  2000 Jun-Jul       Impact factor: 3.825

2.  Comparison of CSF cytology and spinal magnetic resonance imaging in the detection of leptomeningeal disease in pediatric medulloblastoma or primitive neuroectodermal tumor.

Authors:  M Fouladi; A Gajjar; J M Boyett; A W Walter; S J Thompson; T E Merchant; J J Jenkins; J W Langston; A Liu; L E Kun; R L Heideman
Journal:  J Clin Oncol       Date:  1999-10       Impact factor: 44.544

3.  Detection of DNA abnormalities by flow cytometry in cells from cerebrospinal fluid.

Authors:  E S Cibas; M G Malkin; J B Posner; M R Melamed
Journal:  Am J Clin Pathol       Date:  1987-11       Impact factor: 2.493

4.  Magnetic resonance evidence of perineural metastasis.

Authors:  G Hayat; T Ehsan; J B Selhorst; A Manepali
Journal:  J Neuroimaging       Date:  1995-04       Impact factor: 2.486

5.  Phase II trial and pharmacokinetic evaluation of cytosine arabinoside for leptomeningeal metastases from breast cancer.

Authors:  F J Esteva; L T Soh; F A Holmes; W Plunkett; C A Meyers; A D Forman; G N Hortobagyi
Journal:  Cancer Chemother Pharmacol       Date:  2000       Impact factor: 3.333

6.  Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma.

Authors:  Johanna C Bendell; Susan M Domchek; Harold J Burstein; Lyndsay Harris; Jerry Younger; Irene Kuter; Craig Bunnell; Montse Rue; Rebecca Gelman; Eric Winer
Journal:  Cancer       Date:  2003-06-15       Impact factor: 6.860

7.  Leptomeningeal dissemination at diagnosis of pediatric low-grade neuroepithelial tumors.

Authors:  Juliette Hukin; Joao Siffert; Henry Cohen; Linda Velasquez; David Zagzag; Jeffrey Allen
Journal:  Neuro Oncol       Date:  2003-07       Impact factor: 12.300

8.  Whole brain irradiation and intrathecal methotrexate in the treatment of solid tumor leptomeningeal metastases--a Southwest Oncology Group study.

Authors:  W T Sause; J Crowley; H J Eyre; S E Rivkin; R P Pugh; J M Quagliana; S A Taylor; B Molnar
Journal:  J Neurooncol       Date:  1988-09       Impact factor: 4.130

9.  Risk and prognosis of central nervous system leukemia in patients with Philadelphia chromosome-positive acute leukemias treated with imatinib mesylate.

Authors:  Heike Pfeifer; Barbara Wassmann; Wolf-Karsten Hofmann; Martina Komor; Urban Scheuring; Patrick Brück; Anja Binckebanck; Eberhard Schleyer; Nicola Gökbuget; Thomas Wolff; Michael Lübbert; Lothar Leimer; Harald Gschaidmeier; Dieter Hoelzer; Oliver G Ottmann
Journal:  Clin Cancer Res       Date:  2003-10-15       Impact factor: 12.531

10.  Patterns of outcome and prognostic factors in primary large-cell lymphoma of the testis in a survey by the International Extranodal Lymphoma Study Group.

Authors:  E Zucca; A Conconi; T I Mughal; A H Sarris; J F Seymour; U Vitolo; R Klasa; M Ozsahin; G M Mead; M A Gianni; S Cortelazzo; A J M Ferreri; A Ambrosetti; M Martelli; C Thiéblemont; H Gomez Moreno; G Pinotti; G Martinelli; R Mozzana; S Grisanti; M Provencio; M Balzarotti; F Laveder; G Oltean; V Callea; P Roy; F Cavalli; M K Gospodarowicz
Journal:  J Clin Oncol       Date:  2003-01-01       Impact factor: 44.544

View more
  11 in total

1.  Long-term survival of a patient with leptomeningeal involvement by nasopharyngeal carcinoma after treatment with high-dose intravenous methotrexate.

Authors:  Carole Fakhry; Gopal Bajaj; Nafi Aygun; William Westra; Maura Gillison
Journal:  Head Neck       Date:  2010-08-24       Impact factor: 3.147

2.  The clinical experience of medulloblastoma treatment and the significance of time sequence for development of leptomeningeal metastasis.

Authors:  Po-Chuan Hsieh; Chieh-Tsai Wu; Kuang-Lin Lin; Tang-Her Jaing; Chen-Kan Tseng; Tai-Ngar Lui; Shih-Ming Jung
Journal:  Childs Nerv Syst       Date:  2008-09-19       Impact factor: 1.475

3.  CSF protein profiling using Multiplex Immuno-assay: A potential new diagnostic tool for leptomeningeal metastases.

Authors:  Dieta Brandsma; Emile E Voest; Wilco de Jager; Hans Bonfrer; Ale Algra; Willem Boogerd; Tiny Korse; Jaap C Reijneveld; Marcel M Verbeek; Ger Rijkers; Martin J B Taphoorn
Journal:  J Neurol       Date:  2006-09-22       Impact factor: 4.849

4.  Intrathecal gene therapy for treatment of leptomeningeal carcinomatosis.

Authors:  John D Heiss; Sara Taha; Edward H Oldfield; Zvi Ram
Journal:  J Neurooncol       Date:  2010-11-26       Impact factor: 4.130

Review 5.  Metastatic disease of the brain: extra-axial metastases (skull, dura, leptomeningeal) and tumour spread.

Authors:  Roberto Maroldi; Claudia Ambrosi; Davide Farina
Journal:  Eur Radiol       Date:  2004-12-31       Impact factor: 5.315

6.  CSF CA 15-3 in breast cancer-related leptomeningeal metastases.

Authors:  Emilie Le Rhun; Andrew Kramar; Sophie Salingue; Marie Girot; Isabelle Rodrigues; Audrey Mailliez; Fahed Zairi; Edgar Bakhache; Yves Marie Robin; Sophie Taillibert; François Dubois; Jacques Bonneterre; Marc C Chamberlain
Journal:  J Neurooncol       Date:  2014-01-28       Impact factor: 4.130

Review 7.  Strategy of surgery and radiation therapy for brain metastases.

Authors:  Yoshitaka Narita; Soichiro Shibui
Journal:  Int J Clin Oncol       Date:  2009-08-25       Impact factor: 3.402

8.  Meningeal dissemination from an ovarian carcinoma with effective response to intrathecal chemotherapy.

Authors:  Hiromitsu Yamakawa; Haruko Ariga; Akemi Enomoto; Sachiho Netsu; Yuki Suzuki; Ryo Konno
Journal:  Int J Clin Oncol       Date:  2009-10-25       Impact factor: 3.402

Review 9.  Metastasis in Adult Brain Tumors.

Authors:  Ramon Francisco Barajas; Soonmee Cha
Journal:  Neuroimaging Clin N Am       Date:  2016-09-02       Impact factor: 2.264

Review 10.  Perillyl Alcohol and Its Drug-Conjugated Derivatives as Potential Novel Methods of Treating Brain Metastases.

Authors:  Thomas C Chen; Clovis O Da Fonseca; Axel H Schönthal
Journal:  Int J Mol Sci       Date:  2016-09-02       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.